Surplus quantity of active substance used in the manufacturing of a medicinal product to compensate for degradation during manufacture or a product’s shelf life, or to extend shelf life.

Finance Amount of directly contributed equity capital in excess of par value.

Finance Cash flow available after payment of taxes in the project.